| Immunosenescence: implications for response to infection and vaccination in older people A Pera, C Campos, N López, F Hassouneh, C Alonso, R Tarazona, ... Maturitas 82 (1), 50-55, 2015 | 439 | 2015 |
| Immunosenescence of human natural killer cells I Gayoso, B Sanchez-Correa, C Campos, C Alonso, A Pera, JG Casado, ... Journal of innate immunity 3 (4), 337-343, 2011 | 217 | 2011 |
| DNAM-1 and the TIGIT/PVRIG/TACTILE axis: novel immune checkpoints for natural killer cell-based cancer immunotherapy B Sanchez-Correa, I Valhondo, F Hassouneh, N Lopez-Sejas, A Pera, ... Cancers 11 (6), 877, 2019 | 213 | 2019 |
| CMV and Immunosenescence: from basics to clinics R Solana, R Tarazona, AE Aiello, AN Akbar, V Appay, M Beswick, ... Immunity & Ageing 9, 1-9, 2012 | 213 | 2012 |
| NK cells in healthy aging and age‐associated diseases X Camous, A Pera, R Solana, A Larbi BioMed Research International 2012 (1), 195956, 2012 | 166 | 2012 |
| CMV latent infection improves CD8+ T response to SEB due to expansion of polyfunctional CD57+ cells in young individuals A Pera, C Campos, A Corona, B Sanchez-Correa, R Tarazona, A Larbi, ... PloS one 9 (2), e88538, 2014 | 154 | 2014 |
| Shaping of NK cell subsets by aging R Solana, C Campos, A Pera, R Tarazona Current opinion in immunology 29, 56-61, 2014 | 153 | 2014 |
| Functional assessment of allelic variants in the SLC26A4 gene involved in Pendred syndrome and nonsyndromic EVA A Pera, S Dossena, S Rodighiero, M Gandía, G Bottà, G Meyer, F Moreno, ... Proceedings of the National Academy of Sciences 105 (47), 18608-18613, 2008 | 129 | 2008 |
| Effect of age and CMV on NK cell subpopulations C Campos, A Pera, B Sanchez-Correa, C Alonso, I Lopez-Fernandez, ... Experimental gerontology 54, 130-137, 2014 | 123 | 2014 |
| Expansions of Cytotoxic CD4+CD28− T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are … I Broadley, A Pera, G Morrow, KA Davies, F Kern Frontiers in Immunology 8, 195, 2017 | 96 | 2017 |
| A mutational analysis of the SLC26A4 gene in Spanish hearing-impaired families provides new insights into the genetic causes of Pendred syndrome and DFNB4 hearing loss. A Pera, M Villamar, A Vinuela, M Gandía, C Meda, F Moreno, ... European Journal of Human Genetics 16 (8), 888-896, 2008 | 78 | 2008 |
| Proinflammatory status influences NK cells subsets in the elderly C Campos, A Pera, I Lopez-Fernandez, C Alonso, R Tarazona, R Solana Immunology letters 162 (1), 298-302, 2014 | 60 | 2014 |
| De novo mutation in the gene encoding connexin‐26 (GJB2) in a sporadic case of keratitis‐ichthyosis‐deafness (KID) syndrome A Álvarez, I del Castillo, A Pera, M Villamar, MA Moreno‐Pelayo, ... American journal of medical genetics Part A 117 (1), 89-91, 2003 | 59 | 2003 |
| CD28 null CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection A Bano, A Pera, A Almoukayed, THS Clarke, S Kirmani, KA Davies, ... F1000Research 8, F1000 Faculty Rev-327, 2019 | 56 | 2019 |
| Current progress in NK cell biology and NK cell-based cancer immunotherapy R Tarazona, N Lopez-Sejas, B Guerrero, F Hassouneh, I Valhondo, ... Cancer Immunology, Immunotherapy 69, 879-899, 2020 | 51 | 2020 |
| Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies? B Sanchez-Correa, C Campos, A Pera, JM Bergua, MJ Arcos, H Bañas, ... Cancer immunology, immunotherapy 65, 453-463, 2016 | 51 | 2016 |
| CD28null pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular death A Pera, S Caserta, F Albanese, P Blowers, G Morrow, N Terrazzini, ... Theranostics 8 (16), 4509, 2018 | 48 | 2018 |
| Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age C Campos, N López, A Pera, JJ Gordillo, F Hassouneh, R Tarazona, ... Biogerontology 16, 671-683, 2015 | 48 | 2015 |
| CMV induces expansion of highly polyfunctional CD4+ T cell subset coexpressing CD57 and CD154 A Pera, A Vasudev, C Tan, H Kared, R Solana, A Larbi Journal of Leucocyte Biology 101 (2), 555-566, 2017 | 46 | 2017 |
| Immunosenescence: limitations of natural killer cell-based cancer immunotherapy R Tarazona, B Sanchez-Correa, I Casas-Avilés, C Campos, A Pera, ... Cancer Immunology, Immunotherapy 66, 233-245, 2017 | 45 | 2017 |
